Luxiq Side Effects
Please note - some side effects for Luxiq may not be reported. Always consult your doctor or healthcare specialist for medical advice. You may also report side effects to the FDA at http://www.fda.gov/medwatch/ or 1-800-FDA-1088 (1-800-332-1088).
|
For the consumer For the professional
|
|
Side Effects of Luxiq - for the consumer
Luxiq Foam
All medicines may cause side effects, but many people have no, or minor, side effects. Check with your doctor if any of these most COMMON side effects persist or become bothersome when using Luxiq Foam:
Seek medical attention right away if any of these SEVERE side effects occur when using Luxiq Foam:Dry skin; mild, temporary stinging when applied.
TopSevere allergic reactions (rash; hives; itching; difficulty breathing; tightness in the chest; swelling of the mouth, face, lips, or tongue); acne-like rash; burning, cracking, irritation, or peeling not present before you began using Luxiq Foam; excessive hair growth; inflamed hair follicles; inflammation around the mouth; muscle weakness; thinning, softening, or discoloration of the skin; unusual weight gain, especially in the face.
For the professional
Luxiq
The most frequent adverse event was burning/itching/stinging at the application site; the incidence and severity of this event were as follows:
| Incidence and severity of burning/itching/stinging | ||||
| Maximum severity | ||||
| Product | Total incidence | Mild | Moderate | Severe |
| Luxíq Foam n=63 | 34 (54%) | 28 (44%) | 5 (8%) | 1 (2%) |
| Betamethasone valerate lotion n=63 | 33 (52%) | 26 (41%) | 6 (10%) | 1 (2%) |
| Placebo Foam n=32 | 24 (75%) | 13 (41%) | 7 (22%) | 4 (12%) |
| Placebo Lotion n=30 | 20 (67%) | 12 (40%) | 5 (17%) | 3 (10%) |
Other adverse events which were considered to be possibly, probably, or definitely related to Luxíq occurred in 1 patient each; these were paresthesia, pruritus, acne, alopecia, and conjunctivitis.
The following additional local adverse reactions have been reported with topical corticosteroids, and they may occur more frequently with the use of occlusive dressings. These reactions are listed in an approximately decreasing order of occurrence: irritation; dryness; folliculitis; acneiform eruptions; hypopigmentation; perioral dermatitis; allergic contact dermatitis; secondary infection; skin atrophy; striae; and miliaria.
Systemic absorption of topical corticosteroids has produced reversible hypothalamic-pituitary-adrenal (HPA) axis suppression, manifestations of Cushing’s syndrome, hyperglycemia, and glucosuria in some patients.
TopMore resources:
Luxiq Topical - Includes detailed dosage instructions.
Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. In addition, the drug information contained herein may be time sensitive and should not be utilized as a reference resource beyond the date hereof. This information does not endorse drugs, diagnose patients, or recommend therapy. This drug information is a reference resource designed as supplement to, and not a substitute for, the expertise, skill , knowledge, and judgement of healthcare practitioners in patient care. The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug of drug combination is safe, effective, or appropriate for any given patient. Drugs.com does not assume any responsibility for any aspect of healthcare administered with the aid of information provided. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse, or pharmacist.
